NVDA+0.84%AAPL−2.51%GOOGL−1.17%MSFT−2.04%AMZN−0.15%TSM+2.85%SPCX−1.20%AVGO+0.21%
StockVS

NASDAQ · Medical Devices · USD

Bruker Corporation (BRKR) Stock Analysis

Bruker Corporation (BRKR) is a Medical Devices stock listed on NASDAQ and quoted in US Dollar.

BRKR

$58.50

−$0.91 (−1.53%)

Sep 4, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare BRKR with… →

BRKR Key Statistics

As of Sep 4, 2026
Trading
Open
$59.32
Previous Close
$59.41
Day's Range
58.26–59.79
52-Week Range
29.84–65.30
Volume
1.33M
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
1.26
Valuation
Market Cap
$8.91B
P/E Ratio
unprofitable
Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
24.31
PEG RatioThe P/E ratio divided by the expected earnings growth rate. It puts a high P/E in the context of how fast profits are growing.
1.52
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
2.55
EPS (ttm)Profit attributable to each share over the last twelve months.
−0.69
Financials (FY)
Revenue (FY)
$3.44B+2.08%
Net Income (FY)
−$8.60M−107.60%
Profit marginThe share of revenue left as profit after all costs and taxes.
−2.04%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
152.36M
1-Year Return
+97.35%
Dividend and dates
Dividend
$0.20+0.34%
Ex-Dividend Date
September 21, 2026
Earnings Date
November 3, 2026
Avg Volume
2.20M

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

BRKR Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)+24.47%
2025−19.24%
2024−19.99%
2023+7.82%
2022−18.29%
2021+55.35%
2020+6.58%
2019+71.85%
2018−12.82%
2017+62.96%
2016 (partial year)−3.95%

As of September 4, 2026.

BRKR Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$3.44B−$8.60M−0.3%
2024$3.37B$113.10M3.4%
2023$2.96B$427.20M14.4%
2022$2.53B$296.60M11.7%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$3.44B$1.58B$236.00M−$8.60M−0.3%
2024$3.37B$1.65B$379.20M$113.10M3.4%
2023$2.96B$1.51B$489.10M$427.20M14.4%
2022$2.53B$1.31B$462.40M$296.60M11.7%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

BRKR Dividend History

$0.20+0.0% vs 2024

Dividends per share, 2025 · 4 payments

YearDividends per sharePaymentsChange
2026*$0.102—
2025$0.204+0.0%
2024$0.204+0.0%
2023$0.204+0.0%
YearDividends per sharePaymentsChange
2026 (partial year)$0.102—
2025$0.204+0.0%
2024$0.204+0.0%
2023$0.204+0.0%
2022$0.204+25.0%
2021$0.164+0.0%
2020$0.164+0.0%
2019$0.164+0.0%
2018$0.164+0.0%
2017$0.164+300.0%
2016$0.041—

Most recent payment: $0.05 per share, ex-dividend June 22, 2026. Per-share amounts summed by calendar year from ex-dividend dates. Partial years are shown muted and marked with an asterisk.

BRKR Valuation vs Medical Devices Median

Median of 151 stocks
MetricBRKRMedical Devices medianvs median
P/S ratio2.552.9814% below
Profit margin−2.04%−1.69%0.3 pts below

Medians across 151 Medical Devices stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.

Recent News

All 20 articles ↓

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

Bruker Corporation (BRKR) carries a market capitalisation of $8.91B. The company sits in the Healthcare sector, in the Medical Devices industry. Headcount on file is 11,085.

Over the past 52 weeks the price has ranged from $29.84 to $65.30. The most recent close on file for BRKR is $58.50, dated September 4, 2026. That is −$0.91 (−1.53%) against the previous close. The latest close sits 96.05% above that 52-week low.

Financial Health

In fiscal 2025, Bruker Corporation reported revenue of $3.44B. Against the prior fiscal year total of $3.37B, that is a change of +2.08%. The same year closed with a net loss of $8.60M. Profit margin runs at −2.04%. That is 0.3 percentage points below the Medical Devices median of −1.69%. Earnings per share on a trailing basis come to −0.69.

Across the 4 fiscal years on file, revenue moves from $2.53B in 2022 to $3.44B in 2025. Of those 4 years, 3 report positive net income.

Valuation Assessment

The record shows negative trailing earnings, so no price-to-earnings ratio is published. On forward earnings the ratio is 24.31. The PEG ratio, which sets the P/E against expected earnings growth, reads 1.52. Measured against sales, the shares trade at 2.55 times revenue. On price-to-sales that is 14.42% below the Medical Devices median of 2.98. 151 Medical Devices companies report these metrics, and the medians quoted come from that group.

Beta against the wider market is reported at 1.26. Annualized volatility over the trailing 10 years is 38.71%. Over the trailing twelve months the price has returned +97.35%. Across 10 years the annualized return works out at +10.51%.

Growth & Income

The trailing dividend yield is 0.34%. That is 1 percentage points below the Medical Devices median yield of 1.38%. At the indicated rate that is $0.20 a share a year. The ex-dividend date on file is September 21, 2026. Dividends are recorded for 11 calendar years; 2026 shows 2 payments totalling $0.10 a share. The year before, 2025, totalled $0.20 a share.

The strongest complete calendar year on file is 2019 at +71.85%; the weakest is 2024 at −19.99%. Of the 9 complete calendar years on file, 5 finished higher. So far in 2026 the price is +24.47%.

Peer Comparison

Bruker Corporation (BRKR) operates in the Medical Devices industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Bruker Corporation BRKR $8.91B —
Abbott Laboratories ABT $187.45B 35.1
Medtronic plc. MDT $120.46B 22.9
Stryker Corporation SYK $116.27B 31.9

The Medical Devices industry average P/E ratio is 26.8x. Bruker Corporation has no P/E ratio because it is not currently profitable.

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.

Related Medical Devices Stocks

ABT

Abbott Laboratories

$187.45B

 MDT

Medtronic plc.

$120.46B

 SYK

Stryker Corporation

$116.27B

 BSX

Boston Scientific Corporation

$69.27B

 EW

Edwards Lifesciences Corporation

$51.82B

 DXCM

DexCom, Inc.

$33.17B
View all Medical Devices stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.02T

 JNJ

Johnson & Johnson

$663.28B

 ABBV

AbbVie Inc.

$453.19B

 MRK

Merck & Co., Inc.

$370.89B

 UNH

UnitedHealth Group Incorporated

$356.47B
View all Healthcare stocks →

About Bruker Corporation

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions. It operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. The company offers magnetic resonance spectroscop, preclinical imaging, biopharma and applied, services and lifecycle support, integrated data solution, and automation; life science tools; innovative nuclear magnetic resonance (NMR) and electron paramagnetic resonance (EPR) products; solutions for in-vivo processes and drug discovery; aftermarket solutions; solutions for lab automation and digitalization; mass spectrometry solution and test kits, DNA test strips, and fluorescence-based PCR technologies; genotype and fluorotype molecular diagnostics kits; and research, analytical, and process analysis instruments and solutions. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; services for transcriptional profiling and multiomic analysis; superconducting materials, such as metallic low temperature superconductors; multifilament round and rectangular LTS wires in both monolithic and wire-in-channel formats; designs and manufactures Cuponal; metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. Bruker Corporation was founded in 1960 and is headquartered in Billerica, Massachusetts.

Visit website →